65295-69-4

Usage

Chemical Properties

white to light yellow liquid or low melting solid

Uses

2,6-Difluorophenyl isocyanate may be used in chemical synthesis studies.

InChI:InChI=1S/C7H3F2NO/c8-5-2-1-3-6(9)7(5)10-4-11/h1-3H

Upstream product

• 79-37-8 oxalyl dichloride 
• 18063-03-1 2,6-difluorobenzamide 
• 32315-10-9 bis(trichloromethyl) carbonate 
• 5509-65-9 2,6-difluoroaniline 

Downstream Products

• 919120-27-7 C₂₆H₃₄F₂N₄O₂ 
• 919120-26-6 C₂₆H₃₄F₂N₄O₂ 
• 1192713-31-7 1-(2,6-difluorophenyl)-3-(4-((4-oxo-4H-pyrido[1,2-a]pyrimidin-2-yl)methoxy)phenyl)urea 
• 1208106-29-9 1-(2,6-difluorophenyl)-3-(4-(4-oxo-4H-pyrido[1,2-a]pyrimidin-3-yl)phenyl)urea 
• 1192713-22-6 1-(2,6-difluorophenyl)-3-(4-((8-methyl-4-oxo-4H-pyrido[1,2-a]pyrimidin-2-yl)methoxy)phenyl)urea 
• 934188-93-9 ethyl 3-[([(2,6-difluorophenyl)amino]carbonyl)(4-methoxybenzyl)amino]propanoate 
• 1603902-83-5 N-(2,6-difluorophenyl)-4-(2-methyl-5-(2-methyl-1-(2-(trifluoromethyl)pyrimidin-4-ylamino)propan-2-yl)pyrimidin-4-yl)piperidine-1-carboxamide 
• 1603903-58-7 4-(1-{[(2,6-difluorophenyl)amino]carbonyl}piperidin-4-yl)-2,6-dimethyl-N-{[2-(trifluoromethyl)pyrimidin-4-yl]methyl}pyrimidine-5-carboxamide 
• 1603902-05-1 N-(2,6-difluorophenyl)-4-(2,6-dimethyl-5-(5-(2-(trifluoromethyl)pyrimidin-4-yl)-1,3,4-oxadiazol-2-yl)pyrimidin-4-yl)-N-methylpiperidine-1-carboxamide 
• 1603901-86-5 N-(2,6-difluorophenyl)-4-(2,6-dimethyl-5-{5-[2-(trifluoromethyl)pyrimidin-4-yl]-1,3,4-oxadiazol-2-yl}pyrimidin-4-yl)piperidine-1-carboxamide 
• 717894-90-1 1-[4-(4-amino-7-cyclopentyl-7H-pyrrolo[2,3-d]pyrimidine-5-carbonhyl)-phenyl]-3-(2,6-difluoro-phenyl)-urea 
• 1119859-82-3 N-(2,6-difluorophenyl)-3-(([(2,6-difluorophenyl)amino]carbonyl)amino)-1H-indazole-1-carboxamide 

Relevant academic research and scientific papers

SELECTIVE INHIBITORS OF NLRP3 INFLAMMASOME

The present disclosure relates to compounds of Formula (I): (I); and to their pharmaceutically acceptable salts, pharmaceutical compositions, methods of use, and methods for their preparation. The compounds disclosed herein are useful for inhibiting the maturation of cytokines of the IL-1 family by inhibiting inflammasomes and may be used in the treatment of disorders in which inflammasome activity is implicated, such as autoinflammatory and autoimmune diseases and cancers.

Synthesis and nematicidal activity of piperazinedione derivatives based on the natural product Barettin

Nematodes are serious constraints of crop production worldwide. However, the traditional nematicides suffer from the side-effects, including environmental and human toxicity. Herein, more than 70 novel piperazinedione derivatives based on the natural product Barettin were synthesized and evaluated against the root-knot nematode Meloidogyne incognita (M. incognita). While most of synthesized compounds exhibited certain nematicidal activity at high concentration, the best one showed a nematicidal activity of 75% at 2.4 μmol/L.

Design, synthesis and structure-activity relationships of novel diaryl urea derivatives as potential EGFR inhibitors

Two novel series of diaryl urea derivatives 5a-i and 13a-l were synthesized and evaluated for their cytotoxicity against H-460, HT-29, A549, and MDA-MB-231 cancer cell lines in vitro. Therein, 4-aminoquinazolinyl-diaryl urea derivatives 5a-i demonstrated significant activity, and seven of them are more active than sorafenib, with IC50 values ranging from 0.089 to 5.46 μM. Especially, compound 5a exhibited the most active potency both in cellular (IC50 = 0.15, 0.089, 0.36, and 0.75 μM, respectively) and enzymatic assay (IC50 = 56 nM against EGFR), representing a promising lead for further optimization.

N-fluorinated phenyl-N′-pyrimidyl urea derivatives: Synthesis, biological evaluation and 3D-qsar study

With the increase of herbicide-resistant weeds, novel, more selective and even more potent herbicides to control weeds are needed. In this paper, a series of N-fluorinated phenyl-N′-pyrimidyl urea derivatives were synthesized and screened for their herbicidal activities against Amaranthus retroflexus (AR) and Setaria viridis (SV). Compound 25 (N-(3-trifluoromethylphenyl)-N′-(2- amino-4-chloro-6-methylpyrimidyl) urea) exhibited marked herbicidal activity against SV (IC50 = 11.67 mg/L) and is more potent than bensulfuron (IC50 = 27.45 mg/L), a commercially available herbicide. A statistically significant CoMFA model with high prediction abilities (q 2 = 0.869, r2 = 0.989) was obtained.

Synthesis and in vitro antitumor activity of novel diaryl urea derivatives

A series of novel diaryl ureas containing 4-[(2-amino-6-trifluromethyl) pyrimidine-4-yl]piperazine-1-yl group were synthesized and evaluated for their cytotoxic activities in a panel of human cancer cell lines. Compared with the reference drug Sorafenib, some compounds showed more potent and a broader spectrum of anti-cancer activities. Among them, compound 2p demonstrated significant inhibitory activities against MDA-MB-231, HT-29 and MCF-7 cell lines with IC50 values of 0.016, 0.63, 0.001 μmol/L, respectively.

Specific inhibitors of puromycin-sensitive aminopeptidase with a 3-(halogenated phenyl)-2,4(1H,3H)-quinazolinedione skeleton

Specific puromycin-sensitive aminopeptidase (PSA) inhibitors with a 3-(halogenated phenyl)-2,4(1H,3H)-quinazolinedione skeleton were prepared and their structure-activity relationships were investigated. The nature (F, Cl or Br), number and position(s) of the halogen atom(s) introduced into the 3-phenyl group were concluded to be critical determinants of the inhibitory activity.

Synthesis and antiproliferative activitiy of novel diaryl ureas possessing a 4H-pyrido[1,2-a]pyrimidin-4-one group

We herein disclose a series of novel diaryl urea derivatives possessing a 4H-pyrido[1,2-a]pyrimidin-4-one group as novel potent anticancer compounds. The structures were confirmed by IR, 1H-NMR, and MS. All the compounds were screened for their antiprofilerative activity agaist the human breast cancer cell line (MDA-MB-231). The pharmacological results indicated that most of the compounds showed moderate activity. The best of this series is compound 4c (IC50 = 0.7 μmol/L), with a potency 3.6-fold higher than Sorafenib (IC50 = 2.5 μmol/L), which was approved in 2005.

Microwave-assisted synthesis of 1,3,4-thiadiazole aroylurea derivatives

A rapid and efficient microwave-assisted synthesis method for the preparation of 1-aroyl-3-(5-aryl-1,3,4-thiadiazol-2-yl)urea is described. These 1,3,4-thiadiazole aroylureas (5a-f) were identified by IR, 1H NMR, elemental analyses and N-[5-(4-methoxyphenyl)-1,3,4-thiadiazol-2-ylcarbamoyl]-2, 6-difuorobenzamide was confirmed by single-crystal X-ray diffraction. The target compounds were prepared under microwave in a shorter reaction time compared with conventional heating methods.